This document proposes using chewing gum as a delivery method for over-the-counter pharmaceuticals. It notes that chewing gum has a long history and is a multi-billion dollar industry. The document outlines how drugs could be loaded into biodegradable microspheres and released through chewing gum over a sustained period. This approach could reduce medical costs and increase access to care. It discusses testing nicotine and aspirin through this method and developing the business model, including crowd funding and FDA approval. The goal is to deliver drugs non-invasively for conditions like allergies, coughs, and skin issues.
2. Brief History and Economic Impact
Chewing gum has a 5,000 year history!
Post-WWII, ingredients shifted to more
artificial mixes more like polymers now
Sales exceed $20 Billion per year!
2
3. Traditional Uses
Glue or sealer
Blow bubbles (bubble gum)
Relaxation
Breath cleanser
Window putty
3
5. Interesting Uses
Insect repellant (spearmint oil)
Bait for catfish or crabs
Political advertising on wrappers
Personalized party favors
Weight loss
Peak performance enhancer for tests
Recycled as running track or fertilizer
5
6. Re-Framed Use
Non-invasive drug delivery for Over The
Counter (OTC) pharmaceuticals
US Market $23 Billion in 2010
Benefits estimated at $6-7 per $1 of sales or
Range of $138 to 161 Billion times 3 per cent
Estimate Value = $4.14 4.83 Billion per year
(Consumer Health-US, Enomaster Intl, 2011)
6
7. Expected Benefits
Reduce number of sick days
Reduce time off from work for medical office
visits
Increase access for medical care for 180
Million US residents
Avoid the need for costly prescription drugs
(Knowledge Network Survey)
7
8. How Would It Work?
Drugs loaded in biodegradable microspheres
Size up to 1 mm
Drugs best matched for sustained release over
a specific period of time
8
9. Goals
Deliver a pharmaceutical compound to the
body as needed to safely achieve the desired
therapeutic effect.
Modify the drug release profile
absorption, distribution, and elimination for
the benefit of improving product
efficiency, safety as well as patient
convenience and compliance.
9
10. Over The Counter (OTC) Target Areas
Allergies
Analgesics
Anti-fungal
Cough/colds/flu
Lower/upper Gastrointestinal (GI) tract
Medicated skin
10
11. Possible Pathways for Treatments
By mouth
Topical (skin)
Nasal
Vaginal, ocular, rectal or inhalation
11
13. Solution Avoids Most Delivery
Problems
Some drugs require injection or nano-needles
to administer because of molecule size or
charge issues
Others are susceptible to enzyme degradation
No known additional allergy problems
13
14. Next Steps
Use Kickstarter to crowd source startup
funding
Evolve the Business Case Canvas
Complete a pilot that can scale up
Identify and form partnerships
Finish any required FDA testing
14
15. Customer Discovery Philosophy
Ascertain whether theres product/market fit by
finding early evangelists, understanding their
needs, and verifying that the initial minimum viable
product (MVP) solves a problem theyll eagerly pay
to have solved.
If not, use near-continuous customer feedback to
drive agile, frequent changes in product and business
model alike.
15
16. Key Partners
(Others essential to
success of business)
Key Activities
(Potential show stoppers)
(Critical path)
Value Proposition
(Market size;
Product/Service)
(What is the
product/service, its
benefits, and MVP)
Market type hypothesis
and competitive set
differentiation
Customer Relationships
(How will demand be
created?)
Customer Segments
(Who is the customer and
what problems the
product solves?)
Key Resources
(Suppliers, commodities
or other essential
elements)
Channels
(How distributed and
sold?)
Cost Structure
(Inside sales/field sales, development costs,
infrastructure costs, support costs)
Revenue Streams
(Revenue and profit sources and size)
Business Model Canvas (Blank and Dorf, 2012)
16